314 related articles for article (PubMed ID: 8759177)
21. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
Jeppsson S; Rannevik G; Thorell JI
Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
[TBL] [Abstract][Full Text] [Related]
22. The antigonadotropic activity of progestins (19-nortestosterone and 19-norprogesterone derivatives) is not mediated through the androgen receptor.
Couzinet B; Young J; Brailly S; Chanson P; Thomas JL; Schaison G
J Clin Endocrinol Metab; 1996 Dec; 81(12):4218-23. PubMed ID: 8954018
[TBL] [Abstract][Full Text] [Related]
23. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
[TBL] [Abstract][Full Text] [Related]
24. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
MacNaughton J; Banah M; McCloud P; Hee J; Burger H
Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
[TBL] [Abstract][Full Text] [Related]
25. Serum inhibin levels during the periovulatory interval in normal women: relationships with sex steroid and gonadotrophin levels.
McLachlan RI; Cohen NL; Dahl KD; Bremner WJ; Soules MR
Clin Endocrinol (Oxf); 1990 Jan; 32(1):39-48. PubMed ID: 2110047
[TBL] [Abstract][Full Text] [Related]
26. Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report.
Campagnoli C; Biglia N; Lanza MG; Lesca L; Peris C; Sismondi P
Maturitas; 1994 May; 19(1):25-31. PubMed ID: 7935029
[TBL] [Abstract][Full Text] [Related]
27. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
[TBL] [Abstract][Full Text] [Related]
28. Peritoneal fluid volume and levels of steroid hormones and gonadotrophins in peritoneal fluid of normal and norethisterone-treated women.
Kim-Björklund T; Landgren BM; Hamberger L
Hum Reprod; 1991 Oct; 6(9):1233-7. PubMed ID: 1752923
[TBL] [Abstract][Full Text] [Related]
29. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children.
Wide L; Albertsson-Wikland K; Phillips DJ
J Clin Endocrinol Metab; 1996 Jan; 81(1):216-21. PubMed ID: 8550754
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
[TBL] [Abstract][Full Text] [Related]
31. Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
Kapetanakis E; Dmowski WP; Auletta F; Scommegna A
Int J Gynaecol Obstet; 1982 Oct; 20(5):387-99. PubMed ID: 6128271
[TBL] [Abstract][Full Text] [Related]
32. Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
Byrjalsen I; Riis BJ; Christiansen C
Maturitas; 1990 Jun; 12(2):79-88. PubMed ID: 2255265
[TBL] [Abstract][Full Text] [Related]
33. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
Limpaphayom K; Taechakraichana N; Kittinunvorakoon C
J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
[TBL] [Abstract][Full Text] [Related]
34. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
[TBL] [Abstract][Full Text] [Related]
35. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
36. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis.
Bell H; Raknerud N; Falch JA; Haug E
Eur J Endocrinol; 1995 Apr; 132(4):444-9. PubMed ID: 7711882
[TBL] [Abstract][Full Text] [Related]
37. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
Taxel P; Kennedy D; Fall P; Willard A; Shoukri K; Clive J; Raisz LG
Endocr Res; 2000 Aug; 26(3):381-98. PubMed ID: 11019903
[TBL] [Abstract][Full Text] [Related]
38. Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women.
Slowinska-Srzednicka J; Zgliczynski S; Jeske W; Stopinska-Gluszak U; Srzednicki M; Brzezinska A; Zgliczynski W; Sadowski Z
J Endocrinol Invest; 1992; 15(7):533-8. PubMed ID: 1280287
[TBL] [Abstract][Full Text] [Related]
39. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
[TBL] [Abstract][Full Text] [Related]
40. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
